Launch Fast, Prove Consistency: New-Line Laser Drilling + MES Integration for CR Tablets

Context: New controlled-release tablets live or die by the drilled hole. Teams must lock hole geometry quickly and produce audit-ready data from day one. This post outlines typical greenfield problems, our solution stack, and a recent doxazosin CR case.

Industry Problems When Building a New Line

• Parameter discovery: fast alignment of hole presence/size/position with the intended release profile.
• On-line verification: proving uniformity in real time, not by delayed sampling.
• Data integrity at go-live: clear batch records and event/alarm trails under GMP.
• Ramp-up pressure: operators need practical training; validation timelines are tight.

The Solution Architecture We Provide

1. Olando K3-2 laser drilling units installed in GMP-certified cleanrooms.
2. Dual-station vision inspection (closed-loop, real-time rejection).
3. Batch management with an MES/ERP interface.
4. Validation documentation templates (on-site validation is carried out by the end user), plus maintenance training and remote support.

Case Evidence: Doxazosin CR, 2023 (3× K3-2 + MES)

In 2023, a pharma team commissioned three K3-2 systems for a new doxazosin controlled-release tablet project. Each system was deployed in a GMP cleanroom and connected to the plant’s MES. The client reported smooth integration, reliable aperture quality, and consistent output across batches.

Rapid-Launch Checklist

• Translate URS for hole geometry into laser parameters and vision thresholds.
• Run challenge sets to test presence/size/position boundaries.
• Agree on rejection criteria with QA; document periodic challenges.
• Enable e-records; configure MES tags for batches, alarms, and exceptions.
• Complete operator/maintenance training with shift coverage; schedule remote support windows.

Explore Olando K3-2 · See Solution Details · Request Trials or Integration Advice

---

Frequently Asked Questions

Q: How does laser drilling create controlled-release tablets?

A: Laser drilling creates a precise aperture in the tablet coating, forming the drug delivery orifice for osmotic pump tablet systems (OROS technology). The osmotic pressure differential between the tablet core and gastrointestinal fluids drives API release through this aperture at a controlled rate. Hole diameter, depth (blind vs. through-hole), and position are critical parameters. The Olando K3-2 offers ±0.1 mm accuracy and up to 120,000 tablets/hour (based on a 15 mm tablet), with closed-loop vision inspection.

Q: Can the Olando K3-2 drill blind holes and through-holes?

A: Yes — the Olando K3-2 offers 0.9 mm blind/through-hole precision with ±0.05 mm hole depth consistency.

Q: What tablet shapes and sizes can the Olando K3-2 process?

A: The Olando K3-2 handles bilayer round tablets. Supported tablet diameters range from 6 mm to 20 mm. The system processes up to 120,000 tablets/hour (based on a 15 mm tablet).

Q: Is the laser drilling system designed to support FDA 21 CFR Part 11 requirements?

A: The Olando K3-2 Laser Drilling System is designed for cGMP environments, uses a Siemens PLC, and is designed to support 21 CFR Part 11 compliance (audit trail, electronic records, access control). For a full Part 11 workflow (final compliance is established by the end user's own validation), integrate the system's data outputs into a validated manufacturing execution system (MES). Reference customers include Shanghai Modern Pharmaceutical (12 installed units for Nifedipine CR) and Shanghai Xinyi Pharmaceutical (3 units for Doxazosin Mesylate).

Q: What are the ongoing maintenance requirements for laser drilling equipment?

A: The Olando K3-2 solution includes validation documentation templates and operator training; on-site validation is carried out by the end user. Build preventive maintenance into your equipment qualification protocol (IQ/OQ/PQ), and confirm the maintenance plan for your line with Huanghai.